BMS-8
BMS-8 is a novel inhibitor of the PD-1/PD-L1 interaction (IC50: 7.2 μM) by binding directly to PD-L1 and inducing the formation of PD-L1 homodimers.
| Catalog Number | T26859 |
| Research Area | Immunology/Inflammation|||Apoptosis|||Cell Cycle/Checkpoint |
| Molecular Formula | C27H28BrNO3 |
| CAS# | 1675201-90-7 |
| Purity | 99.06% |
| SMILES | Cc1c(COc(ccc(CN(CCCC2)C2C(O)=O)c2)c2Br)cccc1-c1ccccc1 |
| Size | 1 mg |
| Supplier Page | https://www.targetmol.com/compound/BMS-8 |
| Additional Information | https://www.targetmol.com/datasheet/T26859 |